Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sclerosing cholangitis.

E B Martins1, R W Chapman

  • 1Department of Clinical Medicine, Hospital Universitário, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Case of Uterine Polypus Removed by the Ligature, in Which Dilatation of the Os Uteri Was Produced by the Administration of the Lobelia Inflata.

Edinburgh medical and surgical journal·2018
Same author

Editorial: vancomycin - a promising option for the treatment of primary sclerosing cholangitis?

Alimentary pharmacology & therapeutics·2018
Same author

Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B.

Alimentary pharmacology & therapeutics·2016
Same author

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.

Alimentary pharmacology & therapeutics·2016
Same author

A rare cause of colonic thickening and lymphadenopathy.

Gut·2016
Same author

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC.

Alimentary pharmacology & therapeutics·2014
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Primary sclerosing cholangitis (PSC) is a chronic liver disease linked to specific genetic factors. Liver transplantation is the only effective treatment, though PSC can recur post-transplant.

Area of Science:

  • Hepatology
  • Immunogenetics
  • Gastroenterology

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease with unknown causes.
  • Immunogenetic factors, particularly HLA-DRB1, DQA1, DQB1 haplotypes, are implicated in PSC pathogenesis.
  • Liver histology shows portal inflammation with memory T cells, and cholangiocarcinoma is a potential complication.

Purpose of the Study:

  • To summarize the current understanding of primary sclerosing cholangitis.
  • To highlight immunogenetic associations and histological findings.
  • To review treatment options and outcomes, including liver transplantation.

Main Methods:

  • Review of existing literature on primary sclerosing cholangitis.
  • Analysis of immunogenetic associations, including HLA haplotypes.

Related Experiment Videos

  • Evaluation of histological features and disease progression.
  • Assessment of treatment efficacy and outcomes, focusing on liver transplantation.

    • Main Results:

    • Genetic susceptibility to PSC is associated with HLA-DRB1, DQA1, DQB1 haplotypes.
    • Liver histology reveals portal inflammation predominantly by memory T cells.
    • Cholangiocarcinoma may develop, potentially involving p16 tumor-suppressor gene inactivation and alcohol as a risk factor.
    • No medical treatment is proven effective; endoscopic therapy lacks controlled studies.
    • Liver transplantation is the only effective treatment, with improving outcomes but disease recurrence possible.

    Conclusions:

    • Primary sclerosing cholangitis has significant immunogenetic underpinnings.
    • Effective management relies on liver transplantation, despite potential recurrence.
    • Further research is needed for patient selection and optimal timing for liver transplantation.